Literature DB >> 11237798

CD8+ cytotoxic lymphocyte responses against cytomegalovirus after liver transplantation: correlation with time from transplant to receipt of tacrolimus.

A F Hassan-Walker1, A L Vargas Cuero, F M Mattes, P Klenerman, F Lechner, A K Burroughs, P D Griffiths, R E Phillips, V C Emery.   

Abstract

The effects of the immunocompromised state after liver transplantation on the frequency of cytomegalovirus-specific cytotoxic T lymphocytes (CTL) were investigated in 93 patients by using HLA class I tetrameric complexes corresponding to HLA-A*0201, HLA-B*0702, HLA-B*0801, and HLA-B*3501 refolded with peptides from the ppUL83 matrix protein. ppUL83 CTL frequencies were suppressed during the first 6 months after transplantation. Patients with >1 HLA-restricted response detected had high correlation among ppUL83 CD8(+) CTL frequencies restricted by different HLA haplotypes (Spearman's rho=.67; P<.0001). There was an inverse correlation among levels of the calcineurin inhibitor, tacrolimus, and ppUL83 CD8(+) CTL frequencies (r=-.31; P=.005), which is consistent with the presence of a large proportion (70%) of activated (CD38(+)) ppUL83 CD8(+) CTL within the population of HLA class I tetramer-positive cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237798     DOI: 10.1086/319260

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Ex vivo analysis of phenotype and TCR usage in relation to CD45 isoform expression on cytomegalovirus-specific CD8+ T lymphocytes.

Authors:  A L Vargas; F Lechner; M Kantzanou; R E Phillips; P Klenerman
Journal:  Clin Exp Immunol       Date:  2001-09       Impact factor: 4.330

2.  Population analysis of antiviral T cell responses using MHC class I-peptide tetramers.

Authors:  H Komatsu; S Sierro; A V Cuero; P Klenerman
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

Review 3.  Cytomegalovirus and the aging population.

Authors:  V C Emery
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Procedure for preparing peptide-major histocompatibility complex tetramers for direct quantification of antigen-specific cytotoxic T lymphocytes.

Authors:  Xian-Hui He; Li-Hui Xu; Yi Liu
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

5.  Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland.

Authors:  Victoria J Cavanaugh; Yuping Deng; Mark P Birkenbach; Jacquelyn S Slater; Ann E Campbell
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

6.  Cellular responses to cytomegalovirus in immunosuppressed patients: circulating CD8+ T cells recognizing CMVpp65 are present but display functional impairment.

Authors:  M Engstrand; A K Lidehall; T H Totterman; B Herrman; B-M Eriksson; O Korsgren
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

7.  Impact of CMV Reactivation, Treatment Approaches, and Immune Reconstitution in a Nonmyeloablative Tolerance Induction Protocol in Cynomolgus Macaques.

Authors:  Paula Alonso-Guallart; Raimon Duran-Struuck; Jonah S Zitsman; Stephen Sameroff; Marcus Pereira; Jeffrey Stern; Erik Berglund; Nathaly Llore; Genevieve Pierre; Emily Lopes; Sigal B Kofman; Makenzie Danton; Hugo P Sondermeijer; David Woodland; Yojiro Kato; Dilrukshi K Ekanayake-Alper; Alina C Iuga; Cheng-Shie Wuu; Anette Wu; W Ian Lipkin; Rafal Tokarz; Megan Sykes; Adam Griesemer
Journal:  Transplantation       Date:  2020-02       Impact factor: 5.385

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.